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Human single-strand selective monofunctional 
uracil-DNA glyscosylase (hSMUG1) is one of 
three glycosylases encoded within a small region 
of human chromosome 12.  Those three 
glycosylases, uracil-DNA glycosylase (UNG), 
thymine-DNA glyscosylase (TDG) and hSMUG1 
have in common the capacity to remove uracil 
from DNA.  However, these glycosylases also 
repair other lesions and have distinct substrate 
preferences, indicating they have potentially 
redundant, but not overlapping physiological 
roles.  The mechanisms by which these 
glycosylases locate and selectively remove target 
lesions are not well understood.  In addition to 
uracil, hSMUG1 has been shown to remove some 
oxidized pyrimidines, suggesting a role in the 
repair of DNA oxidation damage.  In this 
manuscript, we describe experiments in which a 
series of oligonucleotides containing purine and 
pyrimidine analogs have been used to probe 
mechanisms by which hSMUG1 distinguishes 
potential substrates.  Our results indicate that the 
preference of hSMUG1 for mispaired uracil over 
uracil paired with adenine is best explained by 
the reduced stability of a duplex containing a 
mispair, consistent with previous reports with E. 
coli mispaired DNA glycosylase (MUG).  We have 
also extended the substrate range of hSMUG1 to 
include 5-carboxyuracil, the last in the series of 
damage products from thymine methyl group 
oxidation. The properties used by hSMUG1 to 
select damaged pyrimidines include the size and 
free energy of solvation of the 5-substituent, but 
not electronic inductive properties.  The observed 
distinct mechanisms of base selection 
demonstrated for members of the uracil 
glycosylase family help explain how considerable 
diversity in chemical lesion repair can be 
achieved. 
Three glycosylases that initiate DNA repair 
via the base excision repair (BER) pathway are 
found on human chromosome 12.  These three 
glycosylases are designated as UNG, TDG and 
hSMUG1 (1-4).  Several groups are currently 
investigating the structure and properties of these 
glycosylases in order to determine their 
physiological roles.  A common property of these 
enzymes is the cleavage of uracil residues from 
DNA, although each of the glycosylases repair 
additional lesions.  Despite low sequence homology 
(8%) these three glycosylases share a common fold 
and overall architecture (5).  Subtle differences in 
structure apparently distinguish these repair enzymes 
with respect to substrate and context preferences. 
UNG is the most active of the glycosylases.  
UNG recognizes uracil residues when found in 
single-strand, or double-strand-DNA paired with 
adenine or mispaired with guanine (6), however, 
only a small number of other pyrimidines are also 
targets.  UNG is spliced into two forms, UNG1 and 
UNG2.  UNG1 is targeted to the mitochondrion 
whereas UNG2 is found primarily in the cell nucleus 
(7).  Due to the capacity of UNG to repair uracil in 
many contexts, as well as its association with DNA 
replication machinery and cell cycle specificity it is 
thought that a primary role for UNG is in the repair 
of uracil misincorporated opposite adenine during 
DNA replication (8,9).  Recent studies also suggest 
an important role for UNG in removing uracil 
residues in DNA generated by activation-induced 
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deaminase (AID) as part of somatic hypermutation 
and class switch recombination in activated B-cells 
(10-12). 
In contrast to UNG, the related glycosylases 
hSMUG1 and TDG appear to target uracil and uracil 
analogs mispaired with guanine (3,13,14).  Although 
hSMUG1 was originally characterized as a single-
strand selective glycosylase (13), more recent 
studies suggest it is more active on mispaired uracil 
in duplex DNA (14), and it has an extended substrate 
range, removing several oxidized pyrimidines (15-
18) including 5-hydroxymethyluracil (HmU), 5-
formyluracil (FoU) and 5-hydroxyuracil (HoU).  
TDG appears to act exclusively on duplex substrates, 
with a strong preference for mispaired pyrimidines 
including thymine, and a strong preference for 
damage located in CpG dinucleotides (19-21).  The 
apparent sequence selectivity of TDG has led to 
suggestions that the primary role of TDG is the 
repair of deaminated 5-methylcytosine residues in 
CpG dinucleotides (20). 
In this paper, we have investigated the 
enzymatic properties of recombinant human 
SMUG1 in single-turnover kinetic assays on a series 
of oligonucleotide substrates containing purine and 
pyrimidine analogs.  In the first set of experiments, 
the capacity of hSMUG1 to cleave uracil opposite a 
series of purine analogs was measured to determine 
if the preference of hSMUG1 for mispairs can be 
attributed to reduced duplex stability or if hSMUG1 
recognizes specific functional groups on the purine 
opposite the target uracil.  In the second series of 
experiments, a series of 5-substituted uracil analogs 
was paired opposite guanine to probe the 
mechanisms by which hSMUG1 distinguishes 
potential substrates.  This series includes uracil, a 
series of oxidatively damaged pyrimidines, and the 
5-halouracils which serve to measure both 
substituent size and electronic inductive properties.  
New to this series is 5-carboxyuracil (CaU), the last 
in the sequence of damage products arising from 
oxidation of the thymine methyl group (22-24).   
Previous studies with other glycosylases 
described above have highlighted the importance of 
size and electronic inductive properties of 5-
substituted pyrimidines in substrate selection.  In 
contrast, the capacity of hSMUG1 to recognize 
HmU but not thymine has been attributed to the 
hydrophilicity and hydrogen-bonding capacity of the 
HmU substituent (15-18).  In this paper, selected 
physical properties have been calculated for each 
pyrimidine examined, including solvent accessible 
surface area (SASA) and the free energy of solvation 
in water.  The SASA is introduced as a parameter to 
define the relative size of the 5-substituted 
pyrimidines, whereas the free energy of solvation in 
water is proposed to describe the capacity of the 5-
substituted pyrimidine to interact with or replace 
water within the hSMUG1 pyrimidine binding 
pocket.  The observed kinetic rate constants are 
compared with the physical properties of the 
modified bases and base pairs in order to explain the 
mechanisms by which hSMUG1 identifies and 
distinguishes target lesions.  Our results indicate that 
the strategies used by hSMUG1 to select target bases 
and avoid normal bases contrast with those of other 
members of the uracil DNA-glycosylase family. 
 
 
 
MATERIALS AND METHODS 
 
Oligonucleotide Synthesis and 
Characterization—Oligonucleotides were prepared 
by solid phase synthesis methods as described 
previously (25-28). Following synthesis and 
deprotection, oligonucleotides were purified with 
Poly-Pak II cartridges, and were denaturing-gel 
purified when necessary. The presence of modified 
bases was verified by GC/MS following acid 
hydrolysis and conversion to the trimethylsilyl 
ethers.   
Two sets of oligonucleotides were 
synthesized. A set of oligonucleotide 24-mers 
containing uracil with different 5-substituents (X) 
and purine analogs (P) was synthesized for 
hSMUG1 activity assays (Fig. 1A).    Another set of 
self-complementary 12-mers containing a uracil and 
a purine analog was synthesized for melting 
temperature (Tm ) measurements in which the target 
uracil analog was placed within the same sequence 
context as in the 24-mer glycosylase assays (Fig. 
1B).  A 12-base sequence was selected for the 
thermodynamic studies because the predicted Tm  
would be within an appropriate range for UV 
melting studies (29). The self-complementary 12-
mers were designed by keeping the two adjacent 
bases on each side of the uracil and purine analog 
base pair constant, and linking the two five-base 
fragments in the 5’→3’ orientation.  MALDI-TOF-
MS analysis and Tm’s of the series of 12mers 
examined here have been previously reported (30). 
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Oligonucleotide duplex thermodynamics (ΔGduplex) 
were measured at 100 mM NaCl, 10 mM sodium 
phosphate at pH 7, and Tm values are reported for 28 
μM total strand concentration. 
Preparation and Characterization of the 
Ionization Properties of 5-carboxy-2’-
deoxyuridine—Commercially available 
trifluoromethylthymidine (Sigma-Aldrich, St. Louis, 
MO) was hydrolyzed in alkaline solution to 5-
carboxy-2'-deoxyuridine (31) and purified by silica 
gel chromatography. The identity of 5-carboxy-2'-
deoxyuridine was confirmed by mass spectrometry.  
Ionization constants were determined by 
spectrophotometric titration as previously described 
(32). 
Cloning and Isolation of hSMUG1—RNA of 
hSMUG1 was isolated from HeLa S3 cell line 
(ATCC CCL-2.2) using TRIzol reagent according to 
instructions provided by the manufacturer 
(Invitrogen, Grand Island, NY). mRNA was reverse 
transcribed by using SuperScript First-Strand 
(Invitrogen, Carlsbad, CA) standard protocol.   First-
strand complementary DNA (cDNA) synthesis was 
performed by priming with 20 pmol oligo-dT in 20 
μl reaction mixture containing 10 mM each of 
dATP, dCTP, dGTP, and dTTP, 40 U/μl RNase Out 
Recombinant ribonuclease inhibitor, and 50 U/μl 
SuperScript II RT. The reverse transcription (RT) 
reaction was stopped by cooling to 4oC for 10 min. 
The resulting cDNAs were then amplified with 
Phusion high-fidelity DNA polymerase (New 
England BioLabs, Beverly, MA) according to the 
manufacturer’s instructions. Thirty-six cycles of 
PCR (10 s at 98oC, 30 s at 61 oC and 30 s at 72 oC) 
were performed.   The sequences of oligonucleotides 
used for PCR, were designed based on the cDNA 
sequence of AF125182 reported by Haushalter et al. 
(13). The following sequences were used: 5’-
CGGCGGGGATCCATGCCCCAGGCTTTCCTGC
T-3’ (sense, carries a BamHI restriction site) and 5’-
CTTTTCCTTTTGCGGCCGCTCATTTCAACAGC
AGTGGCAG-3’ (antisense, carries a NotI restriction 
site).  
After resolution of the products by 
electrophoresis in 1% agarose gel, the expected 819 
bp product was extracted using QIAquick gel 
extraction kit (Qiagen, Valencia, CA), and ligated 
into GST fusion expression vector pGEX-4T-1 
(Amersham Pharmacia, Piscataway, NJ) previously 
digested with BamHI and NotI.   Ligated products 
were electroporated into E. coli BL21 Star DE3 
(Invitrogen). The plasmid was isolated and purified 
using a QIAprep Spin Miniprep kit (Qiagen) and 
both strands of the insert were confirmed via 
sequencing (Davis Sequencing, Inc., Davis, CA) 
using the primers: 5’-
TTGGTGGTGGCGACCATCCTCCAA-3’ 
(pGEXmcs5’) and 5’-
CTGCATGTGTCAGAGGTTTTCACC-3’ 
(pGEXmcs3’).     
Purification of Recombinant hSMUG1—To 
purify hSMUG1 expressed as a recombinant protein 
in E.coli, 2 liters of E.coli BL21 Star DE3 carrying 
hSMUG1-GST construct were grown in LB broth 
with 50 µg/ml ampicillin at 37oC until A600 = 0.6-0.7, 
then induced with 0.2 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) overnight at 30oC. 
The cells were harvested by centrifugation, 
resuspended in lysis buffer (50 mM Tris pH 7.4, 150 
mM NaCl, 5 mM MgCl2, 0.01% Triton-X) 
supplemented with 1 mM dithiothreitol (DTT); 1 
mM phenylmethylsulfonyl fluoride (PMSF) and 
incubated at room temperature for 30 min. Lysis was 
then completed by sonicating the suspension on ice 
using a Branson Sonifier Cell Disruptor 200 at 6 
bursts of 10 s each, with a 90 s interval between 
pulses. The lysate was clarified by centrifugation 
(12,000 rpm for 30 min at 4oC) and the supernatant 
was then mixed with swelled glutathione-agarose 
beads (Sigma) and incubated at 4oC overnight with 
gentle agitation.   The suspensions were centrifuged 
at 3,000 rpm for 5 min at 4oC, and the beads were 
washed twice with lysis buffer followed by twice 
with thrombin buffer (50 mM Tris pH 7.4, 150 mM 
NaCl, 5 mM MgCl2, 1 mM DTT).  
The recombinant protein GST-hSMUG1 
was resuspended in 15 ml thrombin buffer, and then 
was cleaved with 100 U/ml thrombin (Sigma) at 
37oC for 1 h, and subsequently purified by FPLC 
using Superdex 75 column (GE Healthcare, 
Piscataway, NJ). The protein was concentrated using 
centricon YM-10 membranes (Millipore, Billerica, 
Massachusetts).   The protein concentration was 
determined using the BCA protein assay reagent kit 
(Pierce Chemical Co., Rockford, IL). The protein 
was analyzed on NuPAGE 4-12% Bis Tris Gels 
(Invitrogen) stained with Simply Blue (Invitrogen) 
and confirmed by western blots using primary 
hSMUG1 antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA). Furthermore, hSMUG1 was 
digested with trypsin following the protocol of 
Matsudaira (33) and analyzed by MALDI-TOF-MS 
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on July 15, 2009 
w
w
w
.jbc.org
D
ow
nloaded from
 
hSMUG1 substrate selectivity 
 4
(data not shown) (Bruker Daltonics, Billerica, MA). 
To further verify that there was no E. coli uracil-
DNA glycosylase contamination after purification, 
we tested the hSMUG1 recombinant activity in the 
presence of a uracil glycosylase inhibitor (UGI) 
using a single-stranded uracil-containing 
oligonucleotide (ssU) corresponding to Fig. 1 as a 
substrate, and as expected, there was no significant 
difference in the amount of excised ssU with or 
without the addition of UGI (data not shown). 
 
Determination of Single-turnover Kinetics on 
Oligonucleotide Substrates. 
Oligonucleotide Labeling and Annealing—
5’-end radiolabeling was performed using 
Adenosine 5’-[γ-32P]triphosphate ([γ-32P]ATP) (MP 
Biomedical, Costa Mesa, CA) and T4 
polynucleotide kinase (New England BioLabs, 
Beverly, MA) under conditions recommended by the 
enzyme supplier. Labeled mixtures were 
subsequently centrifuged through G-50 Sephadex 
columns (Boehringer Mannheim, Indianapolis, IN) 
to remove excess unincorporated nucleotide. 
Labeled single-stranded oligonucleotides were 
annealed to a 2-fold molar excess of unlabeled 
complementary strand in 20 mM Tris-HCl (pH 8.0), 
1 mM EDTA, 1 mM DTT, 0.1 mg/ml BSA and 100 
mM NaCl. The mixture was heated to 95oC for 5 
min and cooled slowly to room temperature. 
Enzymatic Reactions Under Single-turnover 
Conditions—The cleavage rates were determined 
under single-turnover conditions. DNA substrates 
(50 nM) were incubated with 200 nM of hSMUG1 at 
37oC in the reaction buffer containing 20 mM Tris-
HCl (pH 8.0), 1 mM EDTA, 1 mM DTT, 0.1 mg/ml 
BSA and 100 mM NaCl. At selected time points 10 
μl samples were removed and stopped by adding 5 
μl of 0.1 M NaOH and an equal volume of Maxam-
Gilbert loading buffer (98% formamide, 0.01 M 
EDTA, 1 mg/ml xylene cyanol, and 1 mg/ml 
bromophenol blue) and 1 μl (50 pmol) of the of an 
unlabeled complementary oligonucleotide as a 
reannealing competitor. The backbone was cleaved 
at the apyrimidinic sites with NaOH by heating at 
95oC for 30 min. For oligonucleotides containing 
FoU and HoU, reactions were stopped by heating to 
75°C for 5 min, and then cooled to room 
temperature. The abasic site was cleaved by human 
AP endonuclease at 37°C for 1 h in reaction buffer 
provided by manufacturer (Trevigen, Gaithersburg, 
MD). Reaction samples were electrophoresed on 
18% denaturing polyacrylamide gels (8 M urea), and 
the bands corresponding to substrate and products 
were visualized and quantified using a Molecular 
Dynamics PhosphorImager (Molecular Dynamics, 
Sunnyvale, CA, now part of GE Healthcare). The 
reaction rate constant, kobs, was determined by fitting 
time-course data to a single exponential (y = a(1-a-
bx)) using SigmaPlot 10.0, where “a” is the 
maximum level of product ratio and “b” is the 
reaction rate constant, kobs. 
A rapid quench-flow apparatus (RQF-3, 
KinTek Corp., Austin, TX) was used for reactions 
requiring a short time-course (53 ms to 200 s, U:G, 
U:Hx and U:Pu). Rapid quench reactions were 
performed using the standard conditions described 
above except that the reaction volume was 35.5 μl 
and 100 μl of 50 mM NaOH was used to quench 
reactions. The quenched reactions were heated at 
95oC for 30 min to cleave abasic sites, and then 
dried under reduced pressure. DNA was redissoved 
in 20 μl of Maxam-Gilbert loading buffer and 1 μl 
(50 pmol) of the unlabeled complementary 
oligonucleotide was added as a reannealing 
competitor. Samples were analyzed as described 
above. 
 
Computational Methods and Procedures. 
Free Energy of Solvation—In this work, the 
recently developed M06-2X (34) flavor of Density 
Functional Theory (DFT) was used to determine the 
solvation free energy of the various substituted 
uracil analogs. M06-2X has been shown recently to 
provide good accuracy in predicting the binding 
energy and structure of van der Waals complexes 
(35) as it is a hybrid DFT functional with 54% 
Hartree-Fock (HF) meta-exchange in the functional. 
Thus the M06 family of DFT functionals describes 
aromatic-aromatic interactions accurately without 
adding empirical corrections to account for the 
dispersion term which was a limitation of previous 
DFT functionals such as LDA, PW91, PBE, and 
B3LYP (36-40).  
 
Following Kelly et al. (41), the solvation free energy 
can be written as: 
 
( ) ( ) ( )Δ Δ ΔG X G X G Xsolv aq vac gaso o o= −  
(Eq. 1) 
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Where X is the pyrimidine of interest, and with the 
total solvation free energy being the difference in 
free energy between the gas phase electronic 
structure calculation and the aqueous phase 
calculation. These two separate calculations are 
performed for each substituted uracil analog (5 
substituent = Br, CH3, I, Cl, F, CHO, COOH, 
CH2OH, OH, H) as described below.   At 
physiological pH, 5-carboxyuracil would exist 
predominantly as the ionized carboxylate anion.  We 
find that the most accurate way to calculate the free 
energy of solvation is to first calculate the solvation 
free energy of the neutral molecule, and then apply a 
correction determined by the difference between the 
carboxylate pKa and the pH of the solvent (42) as 
discussed below. 
Gas Phase Calculations—The M06-2X DFT 
calculations used the cc-pVTZ(-f)++ basis set and 
were performed with the Jaguar 7.5 quantum 
chemistry software. In several previous studies of 
nitrogen-containing heterocyclic compounds, this 
methodology gave results of high accuracy (43) and 
comparable to higher level of theory such as G3B3 
(44).  The cc-pVTZ(-f)++, which is also denoted as 
"aug-cc-pVTZ"  for augmented correlation-
consistent basis set with polarized valence triple- ,  
is the cc-pVTZ++ basis set of Dunning et al. (45,46). 
For 5-iodouracil, the effective core potentials were 
used on the iodine heavy atom, with the rest of the 
atoms using the cc-pVTZ(-f)++ basis set, and this 
basis set is denoted cc-pVTZ-PP(-f)++. 
The standard Gibbs free energy of each 
substituted uracil analog in the gas phase (42) is 
given by 
 ( )( ) ( )( ) ( )( ) ( )( )Δ ΔG X g E X g ZPE X g G X gsolv 0K 0 298o = + + →
(Eq. 2) 
 
where E0K is the total electronic energy at 0 K, ZPE 
is the zero-point vibrational energy, and G0->298 is the 
Gibbs free energy change from 0 to 298 K at 1 atm 
calculated using the rigid rotor-harmonic oscillator 
approximation without scaling. 
Solution Phase Calculations—The free 
energy of solvation of aromatic compounds in water 
can be obtained by coupling DFT with a Poisson-
Boltzmann (PB) continuum solvent (43). In this 
approach, the solute, described quantum 
mechanically, is immersed in a continuum solvent 
described with a self consistent reaction field 
(SCRF), obtained through numerical solution of the 
Poisson-Boltzmann (PB) equation.  The solute is 
assigned a dielectric constant of 1 (a vacuum), while 
the solute-solvent boundary, described as the solvent 
accessible surface area or SASA, uses standard 
atomic radii taken from Tannor et al. (47,48).  The 
following radii were used: 1.9 Å for sp3-hybridized 
carbon, 1.6 Å for nitrogen and oxygen, and 1.15 Å 
for hydrogen. The solvent is characterized by a 
probe radius (1.4 Å in the case of water) rolled along 
the solute boundary, and having a constant dielectric 
(79.2 for water).  The SASA of the various analogs 
(relative to uracil) are used in Table 1 to include the 
effect of the substituent size on the measured rate. 
The charge distribution of the solute was 
represented by atom-centered point charges adjusted 
to reproduce the electrostatic potential (ESP) derived 
from the QM electron density. The cavity term (used 
to represent the energy required to create the solute 
cavity in the solvent) was calculated using the 
empirical relation given in ref 45. Calculations were 
carried out using both gas-phase geometries and 
geometries optimized in the solvent reaction field. 
 
RESULTS 
 
Oligonucleotides containing a series of 
modified purines and pyrimidines were prepared and 
characterized as previously described (30).  
Sequences used in this study are shown in Fig. 1.  
The free energy of duplex formation for the self-
complementary 12-mer oligonucleotides containing 
purine and pyrimidine analogs was determined from 
UV melting studies and the results are presented in 
Table 1. Recombinant hSMUG1 was overexpressed 
and purified as previously described (13).  
Characterization of the recombinant protein included 
MALDI-TOF-MS analysis of tryptic peptides (data 
not shown).  
In the first series of experiments, hSMUG1 
activity against uracil paired with a series of purines 
was investigated.  An example set of kinetic data is 
shown in Fig. 2.  The measured rate constants (kobs), 
determined under single-turnover conditions, are 
shown in Table 1.   An inverse relationship between 
the natural logarithm of the enzymatic rate constant 
and the free energy of duplex formation was 
observed and is shown in Fig. 3. 
In a second set of experiments, hSMUG1 
single-turnover kinetic activity against a series of 5-
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substituted uracil analogs was measured (Table 1).  
In order to understand the mechanism of base 
selection for the uracil analogs tested, selected 
properties were either measured or calculated for 
each of the uracil analogs examined in the kinetic 
studies.  Rate constants were then compared with 
physical parameters as described below. 
The oxidation of the thymine methyl group 
results in a series of damage products including 
HmU, FoU and CaU.  Although hSMUG1 has been 
shown previously to recognize and remove HmU 
and FoU (15-18), it has not yet been tested with 
CaU.  The carboxyl group of CaU would be 
expected to be ionized under physiological 
conditions.  Ionization of the carboxyl group of CaU 
could also have a profound effect upon ionization of 
the N3 proton.  We therefore prepared 5-carboxy-2’-
deoxyuridine by an established method (31) and 
determined the pKa values for the 5-carboxyl group 
and the N3 proton by spectrophotometric titration 
(32) as shown in Fig. 4.   
The measured pKa values are 4.08 +/- 0.1 
for the 5-carboxyl group and 9.98 +/- 0.1 for the N3 
position.  Previously, we have shown that the pKa of 
the N3 proton of uracil derivatives can be estimated 
based upon the inductive property of the 5-
substituent (49).  In the case of CaU, the ionization 
of the 5-carboxyl group would influence the pKa of 
the N3 proton.  If the 5-carboxyl group was 
unionized, it would withdraw electron density from 
the pyrimidine ring (σm = 0.37, ref 50), predicting a 
pKa for the N3 position of 7.86 +/- 0.14.  
Alternatively, if the carboxyl group was ionized, it 
would donate electron density to the pyrimidine 
ring, predicting a pKa for the N3 proton of 9.90 +/- 
0.14.  Upon the basis of the experimentally 
determined pKa value of the 5-carboxyl group, we 
would expect it to be predominantly ionized at 
physiological pH resulting in an increase in the N3 
pKa relative to 2’-deoxyuridine.  The measured 
value for the pKa of the N3 proton of 9.98 is close to 
the value of 9.90 predicted from the inductive 
property of an ionized carboxyl group (49).    
In a previous study, we demonstrated that 
the rate of base cleavage by MUG was inversely 
proportional to the size of the 5-substituent (52).  In 
that study, we examined only spherical substituents 
whose size could be estimated from van der Waals 
radii and bond lengths.  In the current study, we 
examined several additional pyrimidines with more 
complicated 5-substituents.  We therefore 
determined the solvent accessible surface area 
(SASA) of the uracil analogs with 5-substituents as 
an index of relative size by computational methods 
and the values are presented in Table 1.  The 5-
formyl group of FoU can rotate around the 5-
position and is found in either syn or anti 
conformations as described previously (51).  The 
anti conformation has been determined to be the 
preferred orientation.  Therefore, the SASA value 
for FoU recorded in Table 1 corresponds to the anti 
conformer.  Although SASA values have been 
determined previously for some pyrimidines (53), 
these values have not been determined for the entire 
series of pyrimidines examined here.  
Previous studies have established that 
hSMUG1 can recognize and remove pyrimidine 
damage products with 5-substituents capable of 
hydrogen bonding that could potentially displace 
water molecules from the hSMUG1 pyrimidine 
binding cleft (15-18).  In order to derive a molecular 
property that might be able to quantitatively predict 
the capacity of uracil analogs to bind to hSMUG1, 
we calculated the free energy of solvation in water 
for each substituent and the corresponding values are 
recorded in Table 1.  Although the free energy of 
solvation has been determined for several of the 
substituents examined here in other types of 
molecules (54), the free energy of solvation has not 
been previously calculated for the series of 5-
substituted uracil analogs examined here. 
As discussed above, the formyl group of 
FoU can be found in either syn or anti conformation.  
As the anti conformation is preferred, the free 
energy of solvation for FoU in Table 1 corresponds 
to the anti conformer.  Two of the uracil analogs, 
HoU and CaU, have acidic protons and can be 
ionized under physiological conditions.  In our 
experience, the calculation of the free energy of 
solvation of ionized molecules in water is unreliable 
due to the inherent difficulty in obtaining reliable 
values for the electrostatics of the charged species.  
Therefore, a commonly applied solution is to 
accurately calculate the free energy of solvation for 
the neutral species, and then to apply a correction 
factor based upon pKa values and solution pH to 
account for ionization.  
 ( ) ( )Δ Δ ΔG uracil G uracil Gsolv COO solv COOH pKao o o− = −
(Eq. 3) 
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where 
 
( ) ( ) ( )ΔG RT ln 10 pH pK 1.42 pK pHpK a aao = − × × − = × −
(Eq. 4)   
  
 
The free energy of solvation of HoU in 
water was determined to be -24.17 kcal mol-1 and 
would correspond to the free energy of solvation for 
the neutral molecule when the solvent pH was equal 
to the pKa of the 5-hydroxyl proton.   The measured 
pKa for the 5-hydroxyl group of 5-hydroxy-2’-
deoxyuridine is 7.6 (49), and the hSMUG1 
experiments were performed at pH 8.0 and 37oC. 
The corresponding correction factor would be -0.57 
kcal mol-1, so that the free energy of solvation for 
ionized HoU would be -24.75 kcal mol-1 and -23.60 
kcal mol-1 for neutral HoU at pH 8.0.  The value for 
the neutral species is recorded in Table 1. 
Similarly, the free energy of solvation for 
neutral CaU was calculated to be -24.39 kcal mol-1. 
The experimentally measured value for the pKa of 
the 5-carboxyl proton reported here is 4.08.  As CaU 
would be expected to be predominantly ionized at 
pH 8, a correction factor of 5.57 kcal mol-1 would be 
required.  As the neutral form of CaU would 
spontaneously ionize at pH 8, the free energy of 
solvation of the ionized CaU would be -29.95 
whereas the free energy of solvation of the neutral 
molecule at pH 8 would be -18.83 kcal mol-1.  The 
value for the neutral molecule is recorded in Table 1.  
A complex relationship between the 
observed enzymatic rate constant (kobs) and the 
SASA was observed and is presented in Fig. 5.  The 
natural logarithm of the observed rate constant (ln 
kobs) was observed to decrease linearly with 
increasing SASA for a subset of the analogs 
examined (Fig. 5, inset). The observed enzymatic 
rate constant (kobs) was also observed to decrease 
linearly for several of the pyrimidine analogs except 
uracil as the magnitude of the free energy of 
solvation in water (ΔGosolv) for the corresponding 
pyrimidine became less favorable (Fig. 6).  Further 
relationships between the properties of the analogs 
examined and the observed cleavage rate constants 
were explored and are presented in the Discussion 
section. 
 
 
 
DISCUSSION 
 
Human single-strand selective 
monofunctional uracil-DNA glycosylase, hSMUG1, 
is one of three glycosylases encoded on human 
chromosome 12 that removes uracil from DNA.  
Like the other two glycosylases UNG and TDG, 
hSMUG1 is a monofunctional glycosylase, 
generating an abasic site in the initiation of the base 
excision repair pathway essential for maintaining 
genomic integrity (1-4).  Although UNG, TDG and 
hSMUG1 share many similarities, there are 
significant differences in the range of damaged and 
modified bases acted upon by these enzymes, 
suggesting that they may have unique physiological 
roles in genome maintenance.  In the experiments 
described here, we wished to examine more 
extensively the potential substrates for hSMUG1 and 
to determine the mechanisms by which hSMUG1 
locates and interrogates potential substrates. 
 
In order to accomplish this goal, a series of 
oligonucleotides (Fig. 1) containing purine and 
pyrimidine analogs were constructed and 
characterized using standard methods (30) (see ref. 
52 Fig. 2 for structures of modified purines paired 
with uracil).  Duplex stability was determined by 
measuring the temperature dependence of the 
oligonucleotide UV absorbance at 260 nm in 
aqueous solution as a function of oligonucleotide 
concentration (Table 1).  Several properties of the 
potential uracil analog substrates were determined 
either experimentally or computationally as 
presented in Table 1 and discussed further below.  
The human DNA repair enzyme, hSMUG1 was 
cloned and purified as previously reported (13) and 
characterized by MALDI-TOF-MS.  The capacity of 
hSMUG1 to cleave uracil and its analogs from 
duplex substrates was measured in single-turnover 
kinetic assays as shown in Fig. 2.  Catalytic rate 
constants are presented in Table 1.   Previous studies 
have established that E. coli MUG and hSMUG1 
bind tightly to the abasic-site containing 
oligonucleotide following the removal of a target 
base (13, 14, 52).  Due to the strong product binding 
displayed by some glycosylases, steady-state kinetic 
analysis does not give an accurate reflection of 
relative rates with different potential substrates.  
Single-turnover kinetic conditions are therefore 
required.  Our preliminary studies with hSMUG1 
also indicated strong product binding, and therefore 
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the kinetic studies performed here were conducted 
under single-turnover conditions. 
In our previous study of a related 
glycosylase, E. coli MUG, three parameters were 
identified that are used by MUG to select a target 
pyrimidine (52).  These factors were 1) duplex 
stability: pyrimidines in less stable duplex structures 
were repaired faster, 2) 5-substituent size: 
pyrimidine analogs with smaller 5-substituents were 
repaired faster than those with larger substituents, 
and 3) 5-substituent electronic inductive effects: 
pyrimidines with electron-withdrawing substituents 
in the 5-position were repaired faster than those with 
electron-donating substituents.  Based upon the 
similarities in the enzymatic properties of MUG and 
hSMUG1, it was expected that hSMUG1 would use 
similar strategies for substrate selection.  In this 
study with hSMUG1, we have used the same battery 
of oligonucleotide substrates to probe the 
mechanisms of base selection and we have added 
additional analogs reported to be repaired by 
hSMUG1 including a series of pyrimidines oxidized 
in the 5-position including HmU, FoU CaU and 
HoU.  
In the first study with hSMUG1, the repair 
of a target uracil residue paired opposite a series of 
purine analogs was examined.  The purines selected 
would allow simultaneous assessment of the 
potential impact of the purine on duplex stability and 
could probe for the importance of specific functional 
groups.  Within this series, the target uracil could be 
found in a base pair configuration similar to a 
Watson-Crick base pair with one (U:Pu) two (U:A, 
U:2APu) or three (U:AA) hydrogen bonds, or 
mispaired in a wobble geometry with two hydrogen 
bonds (U:G, U:Hx).  The thermodynamic stability of 
the uracil-containing oligonucleotides within this 
series varies significantly as indicated in Table 1.   
The single-turnover kinetics for the repair of 
uracil within this series of duplex oligonucleotides 
was measured and the observed rate constants (kobs) 
are presented in Table 1.  Inspection of the data 
indicate that the observed rate constants decline as 
the free energy of duplex formation increases.  Note 
that a larger negative value for the free energy of 
duplex formation (ΔGduplex) indicates greater duplex 
stability.  A plot of the natural logarithm of the 
observed rate constant versus the free energy of 
duplex formation is shown in Fig. 3.  The line 
describing the data for the six uracil-containing base 
pairs is indicated in Eq. 5: 
 ( )ln .kobs duplex1.26 G= +Δ 12 35 
(Eq. 5) 
 
A predicted rate constant (kduplex), based upon the 
measured helix stability (ΔGduplex), can then be 
determined (Eq. 6).  In order to compare rate 
constants based upon additional parameters 
described below, a relative rate constant (krel, duplex) 
can be calculated (Eq. 7).  A predicted rate constant 
is converted to a predicted relative rate constant by 
dividing kduplex by the rate constant for the U:G pair 
given by Eq. 6.  Because the U:G pair is common to 
both sets of oligonucleotides used here, the rate 
constant for the U:G pair is used to normalize each 
data set. 
 ( )kduplex 5 1.26 G2.30 10 e duplex= × Δ  
(Eq. 6) ( )k rel,duplex 5 1.26 G8.48 10 e duplex= × Δ  
(Eq. 7) 
 
 
Enzyme cleavage data previously reported 
for MUG is presented with data obtained in this 
study with hSMUG1 (Fig. 3) using a common series 
of oligonucleotide substrates containing purine 
analogs opposite the target uracil.  Linear 
relationships between ln kobs and ΔGduplex are 
observed for both MUG and hSMUG1 however, the 
slope of the line is greater for the hSMUG1 data.  
Within the same sequence context, MUG removes 
uracil mispaired with guanine 25 times faster than 
uracil paired with adenine (52) whereas the 
mispaired uracil is repaired 223 times faster by 
hSMUG1 indicating that hSMUG1 is more selective 
than MUG for mispaired structures.  Within the 
CpG/A dinucleotide sequence examine here, TDG is 
reported to cleave U:G 788 times faster than U:A 
(19). The mechanism for TDG selectivity has not yet 
been reported. 
The known glycosylases flip the target base 
from the duplex into a pyrimidine binding pocket 
within the enzyme prior to hydrolysis of the 
glycosidic bond (5).  While the energetics of base 
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flipping by the glycosylase are not the same as 
duplex melting, we believe that melting differences 
observed within a homologous series of 
oligonucleotides does provide a reasonable estimate 
of the impact of specific base substitutions on the 
energy cost of removing a base from the duplex.  An 
alternative theory is that the glycosylase can 
distinguish uracil mispaired with guanine from 
uracil paired with adenine by interrogating 
functional groups of the purine remaining in the 
duplex following extrusion of the target uracil as 
suggested for MUG (55).  Within the series of 
purines examined here, removal of the guanine 2-
amino group, forming the U:Hx base pair enhanced 
rather than diminished the rate of uracil cleavage.  
Removal of the 6-oxygen and the 2-amino group, 
which also changes the N1 position from a hydrogen 
bond donor to an acceptor (U:G to U:Pu) reduces 
cleavage rates only modestly.   The data reported 
here indicate that hSMUG1 likely exploits the 
reduced stability of mispairs in its search for target 
bases.  The data reported here can not determine 
whether hSMUG1 scans for extruded bases or tests 
for reduced stability of duplex structures. 
An additional, and somewhat unique 
physiological role proposed for hSMUG1 is the 
repair of damaged bases arising from oxidation of 
the thymine methyl group.  Previous studies have 
demonstrated that hSMUG1 can recognize and 
remove the oxidation damage products, HmU, and 
FoU (15-18).  In this study, we have examined for 
the first time the capacity of hSMUG1 to remove 
CaU, the last in the series of thymine methyl group 
oxidation products (Fig. 2 and Table 1).  As 
demonstrated here, hSMUG1 efficiently cleaves 
CaU extending its substrate range and further 
confirming its role in the repair of DNA oxidation 
damage.  In order to more fully understand CaU, its 
ionization constants were measured as shown in Fig. 
4.  The capacity of hSMUG1 to select oxidized bases 
over thymine is remarkable and has been previously 
attributed to water molecules within the pyrimidine 
binding pocket of the glycosylase that could be 
displaced by uracil analogs with hydrogen bonding 
substituents in the 5-position, but not by the thymine 
methyl group (14-18). 
In the studies reported here, we have 
attempted to more fully understand the mechanism 
by which hSMUG1 distinguishes among 5-
substituted uracil analogs.  Previous studies with 
both MUG and TDG have demonstrated that a 
substituent in the 5-position of the uracil analog 
could have a profound impact on the glycosylase 
cleavage rate (52, 56).  In our studies with MUG, we 
demonstrated that smaller and more electron-
withdrawing substituents facilitated cleavage 
whereas larger and more electron-donating 
substituents had the opposite effect.  We therefore 
examined hSMUG1 cleavage of a series of 5-
substituted uracil analogs mispaired with guanine.  
As shown in Table 1, hSMUG1 is observed to 
cleave mispaired FU:G 29 times more slowly than 
U:G.  This was a surprising finding as MUG cleaves 
FU 4.8 times faster than U (52), and TDG cleaves 
FU 78 times faster that U (19).  The selective 
cleavage of FU:G over U:G by MUG was attributed 
to the electron-withdrawing 5-fluoro substituent that 
could potentially stabilize the glycosylase transition 
state (52).  The observation reported here with 
hSMUG1, however, suggests that the inductive 
properties of the 5-substituent are not utilized by 
hSMUG1 for target selection, and therefore the 
hSMUG1 transition state could diverge significantly 
from MUG and TDG.  
Substituent size was shown to be a 
significant factor for base selection by MUG, and we 
wished to test the importance of substituent size with 
hSMUG1 as well.  In the previous study, however, 
we examined only spherical 5-substituents, the size 
of which could be estimated from published bond 
lengths and van der Waals radii.  In order to include 
the additional oxidation products HmU, FoU, CaU 
and HoU, in the analysis, an alternative method was 
needed to estimate the size of the various 5-
substituents.   We therefore calculated the solvent 
accessible surface area (SASA) for each of the 
pyrimidines examined here as shown in Table 1.  All 
of the pyrimidines examined here are 5-substituted 
uracil analogs or uracil.  Differences in the 
calculated SASA within this series can be attributed 
to relative differences in the size of the 5-substituent. 
The activity of hSMUG1 against uracil and 
each of the 5-substituted pyrimidines paired with 
guanine was measured and the observed rate 
constants are recorded in Table 1.  Observed rate 
constants are plotted versus SASA as shown in Fig. 
5.  Inspection of the data in this figure indicates that 
the observed rate constant is not a simple function of 
the SASA.  The magnitude of the rate constant 
declines with increasing SASA for most of the 
analogs.  However, for the oxidation damage 
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products derived from thymine (FoU, CaU and 
HmU) rate constants increase with increasing SASA. 
Measurable rate constants were obtained for 
U:G, FU:G and ClU:G (Table 1).  No cleavage was 
detected for T, BrU or IU.  Unlike the oxidation 
damage products, the halogen substituents would not 
readily form hydrogen bonds with water molecules 
or pyrimidine binding pocket amino acid residues, 
and were therefore used to estimate the impact of 
size alone on the apparent rate constants.  When the 
ln kobs is plotted versus SASA for U:G, FU:G and 
ClU:G, a straight line is obtained (Fig. 5, inset) with 
slope -0.27 and intercept 69.19.  The correlation 
coefficient (r2) with these three data points is 0.99. 
The natural logarithm of the rate constant as 
a function of size, based upon the data presented in 
Fig 5 (inset) is expressed as Eq. 8.  The rate constant 
(kSASA) for a uracil analog with known SASA can 
then be predicted by Eq. 9. 
 ( )ln 0.27 SASA 69.19obsk = − × +  
(Eq. 8) 
 
( )( )kSASA 0.27 SASA 69.19e= − × +   
(Eq. 9) 
 
Within the U, FU and ClU series, the FU and ClU 
analogs have similar electron-withdrawing 
properties, but the U hydrogen substituent is neither 
electron-withdrawing nor electron-donating.  With 
MUG, the observed rate constant dropped by a 
factor of 3 from FU to ClU and this drop was 
attributed to the increased size of Cl relative to F.  
With hSMUG1, the observed rate constant drops by 
a factor of 52 from FU to ClU.  Therefore, the 
pyrimidine binding pocket of hSMUG1 is much 
tighter with respect to the size of the substituent 
alone, and the rate constant drops exponentially with 
increasing substituent size (SASA).  
The observed rate constants for the series U, FU, 
ClU drop exponentially with increasing SASA as 
shown in the inset of Fig. 5.  Cleavage was 
undetectable for T, BrU and IU.  The exponential 
decline of kobs for U, FU, and ClU with increasing 
SASA confirms the absence of an influence of 
substituent inductive effect as discussed above. 
Previous enzymatic and structural studies 
have discussed the capacity of hSMUG1 to 
recognize and cleave oxidation damage products like 
HmU.  It is amazing the hSMUG1 could cleave U, 
avoid T, and cleave the larger HmU.  The 
pyrimidine binding pocket of SMUG1 has bound 
water molecules that form hydrogen bonds with 
amino acid residues lining the pocket.  It has been 
proposed that the hydroxymethyl group of HmU 
could displace the bound water molecules and form 
hydrogen bonds with the pocket whereas this would 
not be possible with the thymine methyl group (13-
18).  The hydroxymethyl group of HmU is 
hydrophilic whereas the thymine methyl group is 
hydrophobic.   
In order to further understand the 
substituents that could form potential hydrogen 
bonds, we sought a parameter that could distinguish 
substituents that favorably interact with water from 
those that did not, such as the thymine methyl group.  
We therefore calculated the free energy of solvation 
in water (ΔG°solv) for each of the pyrimidines 
examined here, the results of which are recorded in 
Table 1.  The magnitude of the free energy of 
solvation is greater for hydrophilic compounds 
(larger, negative values are more favorable) and 
these values become smaller in magnitude and 
approach zero for more hydrophobic compounds.  
Within the series of uracil analogs examined here, 
differences in ΔG°solv can be attributed to the effect 
of the 5-substituent as the remainder of the molecule 
remains constant. 
Observed rate constants are plotted versus 
the free energy of solvation for each pyrimidine in 
Fig. 6.  Rate constants decline as the free energy of 
solvation in water diminishes in magnitude and rate 
constants approach zero when ΔG°solv declines to 
approximately -16 kcal mol-1.  The solvation free 
energy for the ClU analog is -16.6 kcal mol-1 and the 
observed enzymatic rate constant is the lowest 
observed.  The solvation free energy for the BrU, T, 
and IU analogs are less favorable than -16.6 kcal 
mol-1 (Table 1), consistent with no observable 
enzyme cleavage.  The parent pyrimidine uracil does 
not fall on this line.  The 5-hydrogen of uracil is the 
smallest possible substituent, and therefore, size 
rather than the free energy of solvation might 
dominate its enzymatic rate constant. 
The equation for the line in Fig. 6, relating 
the observed rate constant with the solvation free 
energy for the analog is given as Eq. 10. 
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( )kΔ ΔG 3 2solv 5.58 10 G 8.96 10o o= − × − ×− −solv
 (Eq. 10) 
 
 
The free energy of solvation in water reasonably 
accounts for the differences in the observed rate 
constants for several of the analogs recognized by 
hSMUG1.   Analogs with substituents that interact 
well with water would more easily displace or 
rearrange bound water molecules, forming hydrogen 
bonds with amino acid residues or bound water 
molecules.  The model presented here does not 
represent a significant departure from previous 
proposals on the selectivity of hSMUG1 (14-17).  
Rather, the difference between our model and 
previous proposals is that we do not require any 
specific hydrogen bonds between the substituent and 
the enzyme.  Instead, we allow the substituent to 
move, replace, or displace the bound water 
molecules in any manner that minimizes the free 
energy of the system.  We believe the data presented 
here support this model. 
The analogs U, FU and ClU have the most 
similar solvation free energy, but differ significantly 
in size, allowing isolation of the impact of 
substituent size on observed cleavage rate constants 
(Eq. 9).  However, for the remaining analogs, it is 
not possible to isolate size and solvation free energy.  
We therefore constructed an equation combining 
both properties to provide a predicted rate constant 
for the 5-substituent, ksubstituent which is a function of 
both SASA and the free energy of solvation (Eq. 
11).   
 
ksubstituent SASA Gsolv= +k kΔ o   
(Eq. 11) 
 
In this equation, rate constants fall exponentially 
with increasing SASA and increase linearly with 
increasing water solvation free energy.  In order to 
compare this data set with the previous data set 
examining the free energy of duplex formation (Eq. 
7), the predicted rate constant krel,substituent, relative to 
the U:G pair, can be calculated by normalizing to the 
value predicted for U:G according to Eq. 11. The 
relative rate constant predicted based upon the 
combined effects of size (SASA) and free energy of 
solvation for the substituent, krel,substituent can be 
expressed as Eq. 12. 
 
k krel,substituent substituent 0.118=   
(Eq. 12) 
 
The comparison of the observed and expected rate 
constants, combining both size and solvation energy 
according to Eq. 12 is shown in Fig. 7.  Good 
agreement between the expected and observed 
values is obtained indicating that Eq. 11 reasonably 
describes the characteristics for a uracil analog that 
most importantly influence enzymatic rate constants. 
The above consideration of the impact of 
size and solvation free energy has not yet accounted 
for differences in the free energy of duplex 
formation.  Within the series of uracil analogs paired 
with guanine, observed melting temperatures vary 
from 50.4 to 46.3°C, and free energy of duplex 
formation varies from -11.1 to -9.5 kcal mol-1 as 
shown in Table 1.  Although differences in the free 
energy of duplex formation between paired and 
mispaired structures is significantly larger than 
differences between the uracil analogs paired with 
guanine, we wished to combine the parameters 
examined here. 
In order to combine the substituent effect 
with the duplex stability effect, the relative rate 
constants, normalized to the U:G mispair present in 
each set, were combined to provide an equation that 
would predict the rate constant for each of the base 
pairs examined here as  functions of its free energy 
of duplex formation (ΔGduplex) , free energy of 
solvation in water (ΔGosolv), and SASA  as given by 
Eq. 13. 
 ( )( )k k krel,expected rel,duplex rel,substituent=  
 (Eq. 13) 
 
The observed relative enzyme rate constants (krel, 
observed) for the series of mispairs containing damaged 
bases examined in this study is U:G > HoU:G > 
HmU:G > CaU:G > FoU:G > FU:G > ClU:G > 
BrU:G, IU:G, T:G.  The cleavage rates for BrU:G, 
IU:G and T:G were below the limit of detection for 
the experimental methods used here. The expected 
relative rate constants (krel, expected) based upon the 
model presented here is FoU:G > U:G > HoU:G 
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>HmU:G > CaU:G > FU:G > ClU:G > BrU:G > 
IU:G >T:G.  With the exception of FoU:G, the 
model accurately predicts the relative rate constants 
for the series. 
The expected rate constants, determined 
with Eq. 13 and the parameters presented in Table 1 
are compared with the observed relative rate 
constants in Fig. 8.  Most of the points fall on a line; 
however, the expected cleavage rate constants as 
predicted by the model are higher than the relative 
observed rates for FoU:G and HoU:G.  The unusual 
feature of both the FoU:G and HoU:G base pairs is 
that the free energy of duplex formation for both is 
lower than for the U:G base pair (Table 1).  A 
previous study has confirmed that substitution with 
FoU considerably lowers oligonucleotide melting 
temperatures, consistent with the results reported 
here (58).   
We noted that when the expected and 
observed rates were compared, based upon the 
substituent effects alone (Fig. 7) and not including 
duplex energy, all points fell on a line.  However, 
when duplex stability was included (Fig. 8) the 
points for FoU:G and HoU:G deviate from a line 
describing the other base pairs examined.  A 
potential explanation for the apparent anomalous 
behavior of the FoU:G and HoU:G is that reduced 
duplex stability increases enzyme rate constants only 
to a point, and that further reduction of duplex 
stability provides no additional advantage for the 
enzyme.  If the rate of pyrimidine extrusion has 
reached a maximum value when duplex stability 
drops to that of the U:G mispair, another step along 
the reaction coordinate, such as the rate of glycosidic 
bond cleavage might become rate limiting.  
Alternatively, the energetics of duplex melting might 
differ from the energetics of enzymatic base 
extrusion with some modified base pairs due to 
additional chemical properties. In the study reported 
here, both SASA and ΔGosolv were calculated for the 
major conformations of the neutral species.  Both 
FoU and HoU have pKa values near physiological 
pH, and the enzyme active site might alter pKa 
values, and substituents may be found in multiple 
conformations. 
In summary, we have extended the substrate 
range of hSMUG1 to include CaU, the last in the 
series of thymine methyl group oxidation damage 
products.  This result strengthens the suggested role 
for hSMUG1 in the repair of DNA oxidation 
damage.  Our results indicate that hSMUG1 
distinguishes paired from mispaired uracil primarily 
on the basis of reduced duplex stability for the 
mispair and that recognition of specific functional 
groups on the purine in the opposing strand 
contributes minimally.  The most unique property of 
hSMUG1 is its capacity to cleave uracil but not 
thymine, yet still cleave the larger oxidation damage 
products.  The preference of hSMUG1 for U:G over 
T:G can be attributed primarily to the greater size of 
the T methyl group relative to the hydrogen of U.  In 
contrast to other glycosylases, hSMUG1 does not 
exploit the electronic inductive property of the 5-
substituent.  The capacity to recognize and repair 
HmU and other oxidized pyrimidines likely resides 
in a pyrimidine-binding pocket on the enzyme.  In 
accord with previous models, this pocket has mobile 
water molecules that can be displaced or rearranged 
to accommodate some 5-substituents.  Preferred 
substrates carry substituents that can replace 
partially interactions with critical amino acid 
residues vacated by the displaced or rearranged 
water molecules.  The model for selectivity toward 
the oxidized bases presented here does not differ 
conceptually from previous models based upon 
structural studies (15-18).  Rather, we present a 
parameter, the free energy of solvation in water 
(ΔGosolv) that can be used to reasonably describe in a 
quantitative manner the favorable properties 
previously ascribed to the oxidized base targets of 
hSMUG1.  The exploitation of distinct chemical 
properties of damaged and modified bases and base 
pairs by members of the uracil glycosylase family 
provides at the same time necessary discrimination 
between normal and damaged DNA and a broad 
spectrum of possible damage that can be 
accommodated. 
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FOOTNOTES 
 
hSMUG1, Human single-strand selective monofunctional uracil-DNA glycosylase; UNG, uracil-DNA 
glycosylase; MUG, mispaired uracil-DNA glycosylase; TDG, thymine-DNA glycosylase; UGI, uracil glycosylase 
inhibitor; AID, activation-induced deaminase; U, uracil; FU, 5-fluorouracil; ClU, 5-chlorouracil; BrU, 5-
bromouracil; IU, 5-iodouracil; HoU, 5-hydroxyuracil; T, thymine; HmU, 5-hydroxymethyluracil; FoU, 5-
formyluracil; CaU, 5-carboxyuracil; A, adenine; G, guanine; Pu, purine; 2AP, 2-aminopurine; 2AA, 2-
aminoadenine; Hx, hypoxanthine; BER, base excision repair; ss-DNA, single-stranded-DNA; ds-DNA, double-
stranded-DNA; cDNA, complementary DNA; RT, reverse transcription; DFT, density functional theory; HF, 
Hartree-Fock; DTT, dithiothreitol; ESP, electrostatic potential; HEPES, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid; PB, Poisson-Boltzman; IPTG, isopropyl-β-D-thiogalactopyranoside; PMSF, 
phenylmethylsulfonyl fluoride; MALDI-TOF-MS, matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry; SASA, Solvent accessible surface area; SCRF, self-consistent reaction field; σm, sigma meta 
Hammett parameter; Tm, melting temperature. 
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FIGURE LEGENDS 
 
Figure 1. Sequences of oligonucleotides and structures of uracil analogs used in this study. A) 
Oligonucleotide duplex used for glycosylase assays in which X is thymine, uracil or a 5-substituted uracil analog, 
and P is a purine. B) Sequence of the self-complementary oligonucleotide used for the determination of duplex 
stability. C) Structures of uracil analogs.  
 
Figure 2. Kinetic study of hSMUG1 cleavage of 5-substituted uracil analogues paired with guanine 
illustrating the gel electrophoretic assay (left), and time dependent product ratios (right). Single-turnover 
reactions were performed at 37ºC with 50 nM substrate and 200 nM hSMUG1 in the reaction buffer as described 
in materials and methods. Upper panel, HmU:G as a substrate; lower panel, CaU:G as a substrate. 
 
Figure 3. Linear relationship between the free energy of duplex formation, ΔGduplex, and observed cleavage 
rate constants. MUG data from ref 52 is presented as squares and hSMUG1 from this study is presented as 
circles. The natural logarithm of the observed rate constants (ln kobs) for MUG and hSMUG1 are plotted versus 
ΔGduplex. Straight lines are obtained for hSMUG1 with slope 1.26, intercept 12.35, and r2  0.96 and for MUG, 
slope 0.63, intercept 3.02 and r2 = 0.85. 
 
Figure 4. Ionization of 5-carboxyuracil. A) Ionization of the 5-carboxyl group with a pKa of 4.08, B) Ionization 
of the N3 ring nitrogen with a pKa of 9.98, C) Structures of the neutral and ionized forms of CaU.    
 
Figure 5. Relationship between solvent accessible surface area (SASA) and glycosylase kinetics. The 
observed rate constants (kobs) for hSMUG1 cleavage of uracil analogs paired opposite guanine are plotted against 
the SASA.  Inset: The impact of the size alone on the apparent rate constant.  In the inset, values of ln kobs for 
U:G, FU:G and ClU:G  are plotted versus SASA.  A straight line is obtained, with slope -0.27, intercept  69.19 
and r2 0.99. 
 
Figure 6. Relationship between glycosylase cleavage rates and ΔGº solvation. The observed rate constants 
(kobs) for hSMUG1 cleavage of uracil analogs opposite guanine are plotted against ΔGº solvation.  A line is drawn 
through all the points except uracil. The slope of this line is -5.58 x 10-3 with intercept -8.96 x 10-2 and r2 is 0.90.  
 
Figure 7. The comparison of observed rate constants (kobs) and expected rate constants based upon 
substituent characteristics (ksubstituent). The observed rate is plotted against the expected rate based upon Eq. 11.   
A straight line is obtained, with slope 0.83, intercept  0.01 and r2 is 0.97.  
 
Figure 8. Relationship between observed relative rate constants (kobs) and expected relative rate constants 
based on duplex  formation energy of the oligonucleotide, size, and free energy of solvation of the uracil 5-
substituent (krel,expected). The expected relative rates are calculated with respect to the rate of cleavage of the U:G 
base pair according to Eq. 13. A straight line is obtained for several of the analogs with slope 0.98, intercept 9.20 
x 10-3and r2 is 0.99.  Values for the FoU:G and HoU:G pairs do not fall on this line. 
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Table 1: Rate constants and physical characteristics for base pairs examined in this study. The values 
include measured rate constants for hSMUG1 glycosylase cleavage reactions (kobs), melting temperature (Tm) from 
ref. 30 and 52, measured free energy of duplex formation (ΔGduplex) determined from thermal melting studies, 
calculated solvent accessible surface area (SASA) for pyrimidine bases, and calculated free energy of solvation in 
water for pyrimidine bases. Calculated values for SASA and ΔGsolvo correspond to neutral molecules. Calculated 
values for FoU correspond to the anti conformer. 
 
 
 
kobs 
x 103 (s-1) 
Tm (°C) ΔG duplex 
(kcal mol-1) 
SASA 
(Å2) 
ΔGsolvo  
(kcal mol-1) 
U:G 134 ± 15 49.1 ± .01 -10.8 ± 0.4 262.69 -16.76 
U:Hx 634 ± 82 49.0 ± 0.7 -10.4 ± 0.5   
U:Pu 81 ± 5.5 52.4 ± 0.3 -12.1 ± 0.3   
U:A 0.6 ± 0.01 64.4 ± 0.5 -15.9 ± 0.5   
U:2AA 0.4 ± 0.06 66.3 ± 0.5 -15.3 ± 0.9   
U:2AP 2.9 ± 0.1 61.1 ± 0.1 -14.7 ± 0.3   
FU:G 4.7 ± 0.2 48.9 ± 0.4 -10.9 ± 0.4 273.50 -17.20 
ClU:G 0.09 ± 0.006 50.4 ± 0.4 -11.1 ± 0.2 289.43 -16.60 
BrU:G <0.001 50.0 ± 0.3 -11.1 ± 0.2 298.05 -16.47 
IU:G <0.001 49.9 ± 0.3 -11.1 ± 0.4 308.35 -16.18 
HoU:G 41.4 ± 2.5 49.2 ± 0.4 -10.4 ± 0.5 270.02 -23.60 
T:G <0.001 50.2 ± 0.1 -11.3 ± 0.3 286.95 -16.16 
HmU:G 34.8 ± 1.8 49.5 ± 0.5 -11.1 ± 0.2 299.04 -22.54 
FoU:G 13.3 ± 0.8 46.3 ± 0.2 -9.50 ± 0.2 293.24 -19.17 
CaU:G 25.8 ± 1.9 49.7 ± 0.4 -11.0 ± 0.4 296.81 -18.83 
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Figure 1. Sequences of oligonucleotides and structures of uracil analogs used in this study. A) 
Oligonucleotide duplex used for glycosylase assays in which X is thymine, uracil or a 5-substituted uracil analog, 
and P is a purine. B) Sequence of the self-complementary oligonucleotide used for the determination of duplex 
stability. C) Structures of uracil analogs.  
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Figure 2. Kinetic study of hSMUG1 cleavage of 5-substituted uracil analogues paired with guanine 
illustrating the gel electrophoretic assay (left), and time dependent product ratios (right). Single-turnover 
reactions were performed at 37ºC with 50 nM substrate and 200 nM hSMUG1 in the reaction buffer as described 
in materials and methods. Upper panel, HmU:G as a substrate; lower panel, CaU:G as a substrate. 
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Figure 3. Linear relationship between the free energy of duplex formation, ΔGduplex, and observed cleavage 
rate constants. MUG data from ref 52 is presented as squares and hSMUG1 from this study is presented as 
circles. The natural logarithm of the observed rate constants (ln kobs) for MUG and hSMUG1 are plotted versus 
ΔGduplex. Straight lines are obtained for hSMUG1 with slope 1.26, intercept 12.35, and r2  0.96 and for MUG, 
slope 0.63, intercept 3.02 and r2 = 0.85. 
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Figure 4. Ionization of 5-carboxyuracil. A) Ionization of the 5-carboxyl group with a pKa of 4.08, B) 
Ionization of the N3 ring nitrogen with a pKa of 9.98, C) Structures of the neutral and ionized forms of 
CaU.    
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Figure 5. Relationship between solvent accessible surface area (SASA) and glycosylase kinetics. The 
observed rate constants (kobs) for hSMUG1 cleavage of uracil analogs paired opposite guanine are plotted against 
the SASA.  Inset: The impact of the size alone on the apparent rate constant.  In the inset, values of ln kobs for 
U:G, FU:G and ClU:G  are plotted versus SASA.  A straight line is obtained, with slope -0.27, intercept  69.19 
and r2 0.99. 
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Figure 6. Relationship between glycosylase cleavage rates and ΔGº solvation. The observed rate constants 
(kobs) for hSMUG1 cleavage of uracil analogs opposite guanine are plotted against ΔGº solvation.  A line is drawn 
through all the points except uracil. The slope of this line is -5.58 x 10-3 with intercept -8.96 x 10-2 and r2 is 0.90.  
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Figure 7. The comparison of observed rate constants (kobs) and expected rate constants based upon 
substituent characteristics (ksubstituent). The observed rate is plotted against the expected rate based upon Eq. 11.   
A straight line is obtained, with slope 0.83, intercept  0.01 and r2 is 0.97.  
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Figure 8. Relationship between observed relative rate constants (kobs) and expected relative rate constants 
based on duplex  formation energy of the oligonucleotide, size, and free energy of solvation of the uracil 5-
substituent (krel,expected). The expected relative rates are calculated with respect to the rate of cleavage of the U:G 
base pair according to Eq. 13. A straight line is obtained for several of the analogs with slope 0.98, intercept 9.20 
x 10-3and r2 is 0.99.  Values for the FoU:G and HoU:G pairs do not fall on this line. 
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